Abstract
BackgroundOH2 is a genetically engineered oncolytic herpes simplex virus type 2 designed to selectively amplify in tumor cells and express granulocyte-macrophage colony-stimulating factor to enhance antitumor immune responses. We investigated...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have